ESR1 and neoplasm: Intriguingly, patients with BCK-high ER+ tumors experience improved outcomes in univariable and multivariable analysis (Fig. 5d and Supplementary Fig. 12f), and although entirely speculative at this point in time, one could hypothesize that this might be due to increased anti-tumor immune activation.